A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer&#39;s disease.

COYA 301 - Coya Therap

http://www.ncbi.nlm.nih.gov/pubmed/37968718

Aaron D Thome; Abdulmunaim M Eid; Alireza Faridar; Charles S Davis; David R Beers; Gustavo C Román; Joseph C Masdeu; Maria B Pascual; Michael Grundman; Mohammad O Nakawah; Stanley H Appel; Weihua Zhao

Nov 16, 2023